The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design

Схожие документы

• Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
  по: Tongo, Marcel, et al.
  Опубликовано: (2013)
• Profile of T Cell Recognition of HIV Type 1 Consensus Group M Gag and Nef Peptides in a Clade A1- and D-Infected Ugandan Population
  по: Serwanga, Jennifer, et al.
  Опубликовано: (2012)
• P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity
  по: Tongo, M, et al.
  Опубликовано: (2009)
• Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides()
  по: Mugaba, S., et al.
  Опубликовано: (2014)
• Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials
  по: Zembe, Lycias, et al.
  Опубликовано: (2011)